Cargando…

Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China

BACKGROUND: Lateral pelvic lymph node (LPN) metastasis causes increased lateral local recurrence and poor prognosis. We aimed to investigate the prognostic significance and effective range of dissection for the LPN dissection (LPND) in rectal cancer patients with LPN metastasis. MATERIALS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Sicheng, Tang, Jianqiang, Liang, Jianwei, Lou, Zheng, Fu, Wei, Feng, Bo, Yang, Yingchi, Xiao, Yi, Liu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413157/
https://www.ncbi.nlm.nih.gov/pubmed/36033473
http://dx.doi.org/10.3389/fonc.2022.916285
_version_ 1784775671839457280
author Zhou, Sicheng
Tang, Jianqiang
Liang, Jianwei
Lou, Zheng
Fu, Wei
Feng, Bo
Yang, Yingchi
Xiao, Yi
Liu, Qian
author_facet Zhou, Sicheng
Tang, Jianqiang
Liang, Jianwei
Lou, Zheng
Fu, Wei
Feng, Bo
Yang, Yingchi
Xiao, Yi
Liu, Qian
author_sort Zhou, Sicheng
collection PubMed
description BACKGROUND: Lateral pelvic lymph node (LPN) metastasis causes increased lateral local recurrence and poor prognosis. We aimed to investigate the prognostic significance and effective range of dissection for the LPN dissection (LPND) in rectal cancer patients with LPN metastasis. MATERIALS AND METHODS: Through this large, multicenter retrospective cohort study, we evaluated the therapeutic effect of LPND. From January 2012 to December 2019, 387 rectal cancer patients with clinical evidence of LPN metastasis who underwent total mesorectal excision with LPND were included in the study. According to pathological findings, they were divided into negative (n = 296) and positive (n = 91) LPN groups. Primary endpoints were 3-year overall survival (OS), recurrence-free survival (RFS), and local recurrence-free survival (LRFS). RESULTS: The OS, RFS, and LRFS in the positive group were significantly worse than those in the negative group; However, LPN metastases were not independent prognostic risk factors for LRFS (hazard ratio [HR]: 2.42; 95% confidence interval [CI], 0.77–7.64; P=0.132). Among patients with pathological LPN metastases, LPN metastases to the common and external iliac arteries were independent prognostic risk factors both for OS (HR: 4.74; 95% CI, 1.74–12.90; P=0.002) and RFS (HR: 2.70; 95% CI, 1.16–6.29; P=0.021). No significant difference was observed in the 3-year OS (72.3% vs. 70.2%, P=0.775) and RFS rates (60.9% vs. 52.6%, P=0.408) between patients with metastases to the obturator or internal iliac arteries and patients at N2b stage. CONCLUSIONS: LPND may be effective in controlling local recurrence in patients with LPN metastasis but not systemic metastases. Patients with LPN metastasis limited to the internal iliac and obturator regions achieve a long-term survival benefit from LPND, and their prognoses may be comparable to those at the N2b stage. Further metastasis to the external iliac or common iliac region should be considered systemic disease, and LPND should be avoided. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, identifier NCT04850027.
format Online
Article
Text
id pubmed-9413157
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94131572022-08-27 Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China Zhou, Sicheng Tang, Jianqiang Liang, Jianwei Lou, Zheng Fu, Wei Feng, Bo Yang, Yingchi Xiao, Yi Liu, Qian Front Oncol Oncology BACKGROUND: Lateral pelvic lymph node (LPN) metastasis causes increased lateral local recurrence and poor prognosis. We aimed to investigate the prognostic significance and effective range of dissection for the LPN dissection (LPND) in rectal cancer patients with LPN metastasis. MATERIALS AND METHODS: Through this large, multicenter retrospective cohort study, we evaluated the therapeutic effect of LPND. From January 2012 to December 2019, 387 rectal cancer patients with clinical evidence of LPN metastasis who underwent total mesorectal excision with LPND were included in the study. According to pathological findings, they were divided into negative (n = 296) and positive (n = 91) LPN groups. Primary endpoints were 3-year overall survival (OS), recurrence-free survival (RFS), and local recurrence-free survival (LRFS). RESULTS: The OS, RFS, and LRFS in the positive group were significantly worse than those in the negative group; However, LPN metastases were not independent prognostic risk factors for LRFS (hazard ratio [HR]: 2.42; 95% confidence interval [CI], 0.77–7.64; P=0.132). Among patients with pathological LPN metastases, LPN metastases to the common and external iliac arteries were independent prognostic risk factors both for OS (HR: 4.74; 95% CI, 1.74–12.90; P=0.002) and RFS (HR: 2.70; 95% CI, 1.16–6.29; P=0.021). No significant difference was observed in the 3-year OS (72.3% vs. 70.2%, P=0.775) and RFS rates (60.9% vs. 52.6%, P=0.408) between patients with metastases to the obturator or internal iliac arteries and patients at N2b stage. CONCLUSIONS: LPND may be effective in controlling local recurrence in patients with LPN metastasis but not systemic metastases. Patients with LPN metastasis limited to the internal iliac and obturator regions achieve a long-term survival benefit from LPND, and their prognoses may be comparable to those at the N2b stage. Further metastasis to the external iliac or common iliac region should be considered systemic disease, and LPND should be avoided. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, identifier NCT04850027. Frontiers Media S.A. 2022-08-12 /pmc/articles/PMC9413157/ /pubmed/36033473 http://dx.doi.org/10.3389/fonc.2022.916285 Text en Copyright © 2022 Zhou, Tang, Liang, Lou, Fu, Feng, Yang, Xiao and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhou, Sicheng
Tang, Jianqiang
Liang, Jianwei
Lou, Zheng
Fu, Wei
Feng, Bo
Yang, Yingchi
Xiao, Yi
Liu, Qian
Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China
title Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China
title_full Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China
title_fullStr Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China
title_full_unstemmed Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China
title_short Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China
title_sort effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: results of a large multicenter lateral node collaborative group in china
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413157/
https://www.ncbi.nlm.nih.gov/pubmed/36033473
http://dx.doi.org/10.3389/fonc.2022.916285
work_keys_str_mv AT zhousicheng effectivedissectingrangeandprognosticsignificanceoflateralpelviclymphnodedissectionformiddlelowrectalcancerpatientswithlateralpelviclymphnodemetastasisresultsofalargemulticenterlateralnodecollaborativegroupinchina
AT tangjianqiang effectivedissectingrangeandprognosticsignificanceoflateralpelviclymphnodedissectionformiddlelowrectalcancerpatientswithlateralpelviclymphnodemetastasisresultsofalargemulticenterlateralnodecollaborativegroupinchina
AT liangjianwei effectivedissectingrangeandprognosticsignificanceoflateralpelviclymphnodedissectionformiddlelowrectalcancerpatientswithlateralpelviclymphnodemetastasisresultsofalargemulticenterlateralnodecollaborativegroupinchina
AT louzheng effectivedissectingrangeandprognosticsignificanceoflateralpelviclymphnodedissectionformiddlelowrectalcancerpatientswithlateralpelviclymphnodemetastasisresultsofalargemulticenterlateralnodecollaborativegroupinchina
AT fuwei effectivedissectingrangeandprognosticsignificanceoflateralpelviclymphnodedissectionformiddlelowrectalcancerpatientswithlateralpelviclymphnodemetastasisresultsofalargemulticenterlateralnodecollaborativegroupinchina
AT fengbo effectivedissectingrangeandprognosticsignificanceoflateralpelviclymphnodedissectionformiddlelowrectalcancerpatientswithlateralpelviclymphnodemetastasisresultsofalargemulticenterlateralnodecollaborativegroupinchina
AT yangyingchi effectivedissectingrangeandprognosticsignificanceoflateralpelviclymphnodedissectionformiddlelowrectalcancerpatientswithlateralpelviclymphnodemetastasisresultsofalargemulticenterlateralnodecollaborativegroupinchina
AT xiaoyi effectivedissectingrangeandprognosticsignificanceoflateralpelviclymphnodedissectionformiddlelowrectalcancerpatientswithlateralpelviclymphnodemetastasisresultsofalargemulticenterlateralnodecollaborativegroupinchina
AT liuqian effectivedissectingrangeandprognosticsignificanceoflateralpelviclymphnodedissectionformiddlelowrectalcancerpatientswithlateralpelviclymphnodemetastasisresultsofalargemulticenterlateralnodecollaborativegroupinchina